SCHEMBL4730653

SCHEMBL4730653

CC(=O)c1cc(N)cc(C(N)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FURIN P09958 1/20 0.45
CA5A P35218 1/20 0.44
TSHR P16473 2/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CREBBP Q92793 1/20 0.38
NOS1 P29475 3/20 0.38
NOS3 P29474 2/20 0.38
LMNA P02545 2/20 0.38
CYP3A4 P08684 2/20 0.38
PARP1 P09874 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DHODH Q02127 1/20 0.37
PRKCI P41743 1/20 0.37
PARP10 Q53GL7 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090099 0.91 CA5A (0.52) CA5ATSHRMKNK1MKNK2MAPT
SCHEMBL1976289 0.91 CA5A (0.52) FURINCA5ATSHRMAPTNPC1
SCHEMBL1807992 0.88 KDM4E (0.46) FURINTSHRMAPTKDM4ELMNA
SCHEMBL2628599 0.85 CA5A (0.52) FURINCA5AMAPTNPC1RAB9A
Iodide SCHEMBL9844728 0.85 KDM4E (0.45) FURINTSHRMAPTKDM4ELMNA
SCHEMBL890399 0.83 CYP3A4 (0.44) FURINTSHRMAPTKDM4ELMNA
SCHEMBL13790658 0.82 DHODH (0.55) CA5ATSHRMKNK1MKNK2MAPT
SCHEMBL12666031 0.82 TPMT (0.50) FURINCA5ATSHRMAPTNPC1
Hydrochloric Acid SCHEMBL9563848 0.80 CYP3A4 (0.43) FURINTSHRMAPTKDM4ELMNA
SCHEMBL3661752 0.79 DHODH (0.57) CA5ATSHRMKNK1MKNK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008054454-A2 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF AS ANTIVIRAL AGENTS TRANSTECH PHARMA, INC. (US) 2008-05-08 WO disclosed
US-20070219239-A1 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219239-A1 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents NUDT1, PNP, NME2 FURIN 254/4885CA5A 1483/4885TSHR 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.